Țară: Armenia
Limbă: engleză
Sursă: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
pitavastatin (pitavastatin calcium)
Recordati Industria Chimica e Farmaceutica S.p.A.
C10AA08
pitavastatin (pitavastatin calcium)
1mg
tablets film-coated
(28/2x14/) in blister
Prescription
Registered
2019-03-25
Recordati Leland Ltd. SUMMARY OF PIIODUCT CHAITACTERISTICS NAME O}- THE MI,DICINAL PRODUCT Livazo I mg filnr-coated tablets. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each fihr-coated lablet contains pitavastatin calcium equivalerrt to I mg Pitavastatin. Excipient(s) include 63.085mg Laclose monohydrate For a full list ofexcipients see section 6 I 3. PHARMACEUTICAL FORM Film-coated tablel. Round white film-coated tablets embossed 'KC' ot't one face and '1' on the Ieverse. 4. CI,INICALPARTICULARS 4.t Therapeuticindications Livazo is inclicated tbr the rcductiorr of clevated total cllolesterol (lC) and l-Dl.-C. in adults. adolescents ancl childlen aged 6 years or older with prinrary hyperclto Iestcro laenr ia. incltrding heterozygous fanilial hypercho lestero laerr ia, aud coltbirted (nrixed) dyslipidaemia. u'hen respo!rsc lo diet and other non-pharmacological moasures is inadequate. 4.2 Posology and method of Ad nr inistration Posoloqy patients should be on a cholestorol lorvering diet befbre treatrnent. It is inlpotlant that a!l patients continue dietary control during treatnlerlt. The usual startirrg dose is lmg once daily. Adjustment ofdose should be made at intervals ot 4 weeks or more. Doses should be individualized according to LDL-C levels, the goal of therapy and patient response. The maximttm daily dose is 4mg Ekle-rly No dose adjustment necessary in patients older than 70 years (see sectiorl!-! arrd Sef1iolllj' Pagdi4lrs-pgpdalql Childrett qnd adolescents aged 6 years and over" Livazo use ip childrerr shoulcl only be carried out by physicians exper-ienced in thc treatnlent of hyperlipidaerr ia and progress should be regulatly reviewed. l-ivazo l ng filrn-coaled tabiels u Kr-l/155iio3rDC starting dose Doses should ildrcn 6 tt: In chilclren and aclolescents with heterorygous farnilial hypercholesterolaelnia the ustlal is lng once daily. Adjustrrent ofdose shrltrld bcmadeat inlervals of4 rveeks ot more be individualized aocording to LDL-C levels. the 9 years oI age the tnaxintunl daily dose is 2rng ln is Citiți documentul complet